分析糖尿病患者伴发抑郁症的临床对照研究

Analysis of Diabetes Patients Complicated With Depression Clinical Control Study

目的探讨帕罗西汀应用于糖尿病患者并发抑郁症的临床治疗效果。方法选择我院2014年1月～2015年3月收治的患有糖尿病伴发抑郁症患者典60例，分为观察组及对照组，每组各30例患者，对比两组患者的临床治疗效果。结果观察组30例患者经临床治疗显效患者12例，经临床治疗有效患者14例，其临床治疗有效率高达86．67％；相比较对照组30例患者临床治疗显效患者6例，经临床治疗有效患者10例，其临床治疗有效率为53．33％，观察组患者的临床治疗效果优于对照组患者的临床治疗效果。结论糖尿病伴发抑郁症患者的临床治疗首先针对抑郁症进行治疗可改善血糖的控制效果。即帕罗西汀应用于糖尿病患者并发抑郁症的临床治疗效果显著，具有临床中讲一步研究应用的价植．

Objective To investigate paroxetine applied to clinical outcomes in diabetic patients complicated by depression. Methods 60 patients with major depression were divided into observation group and control group in our hospital in January 2014-March 2015, 30 patients in each group clinical, compared two groups of patients treatment. Results The group of 30 patients with clinical patients showed 12 patients clinically effective treatment of 14 patients, whose clinical efficiency as high as 86.670, compared with the control group, the clinical treatment of 30 patients were cured in 6 patients, the clinical treatment effective 10 patients, the clinical effective rate was 53.33%, the clinical effect of the observation group were significantly better clinical outcomes of patients in the control group. Conclusion Diabetic patients with depressive disorder first clinical treatment for depression can significantly improve glycemic control effect. That applies to diabetic patients with paroxetine for depression clinical effect is significant, with a value in further clinical research applications.